• no-js

About us

Computational Cardiovascular Science aims at the combination of computational methods in cardiovascular research to integrate and expand the information extracted from a range of experimental and clinical data including biosignals and medical images.

Our group is part of the BHF Centre of Research Excellence at Oxford, and includes scientists based at the Department of Computer Science and the Bioengineering Institute, with strong links with the Departments of Cardiovascular Medicine and Physiology, and established collaborations with clinical and experimental collaborators in academia, hospitals, pharmaceutical companies and regulatory agencies.

Latest News

Interested in joining us for a DPhil/PhD in Oxford Computational Cardiovascular Science?

Posted 11/11/2021
Several routes listed below. Please read through requirements, check alignment with our latest publications and research programme, and send your application before the deadline:

Best poster presentation at FiMH 2021

Posted 16/06/2021
Alfonso Beuno-Orovio in collaboration with Rafa Sebastian's group received the best post presentation award at FiMH 2021. Take a look (limited free access until end of July.

The Rosanna Degani Young Investigator Finalist Award at CinC 2021

Posted 16/06/2021
Francesca Margara awarded Finalist award of the CinC Rosanna Degani Young Investigator Award

The Rosanna Degani Young Investigator Semi-Finalist Awards at CinC 2021

Posted 16/06/2021
Julia Camps and James Coleman both were Semi-Finalists of the CinC 2021 Rosanna Degani Young Investigator Award.

News & Events Archive

Latest Publications

Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility

Musuamba FT, Skottheim Rusten I, Lesage R, Russo G, Bursi R, Emili L, Wangorsch G, Manolis E, Karlsson KE, Kulesza A, Courcelles E, Boissel JP, Rousseau CF, Voisin EM, Alessandrello R, Curado N, Dall'ara E, Rodriguez B, Pappalardo F, Geris L. CPT Pharmacometrics Syst Pharmacol, 2021. doi: 10.1002/psp4.12669.

Applying the CiPA Approach to Evaluate Cardiac Proarrhythmia Risk of some Antimalarials Used Off-label in the First Wave of COVID-19

Delaunois A et al. Clin Transl Sci (2021). doi: 10.1111/cts.13011

Comparison of the Simulated Response of Three in Silico Human Stem Cell-Derived Cardiomyocytes Models and in Vitro Data Under 15 Drug Actions

Paci M, Passini E, Klimas A, Severi S, Hyttinen J, Rodriguez B, Entcheva E. In Silico hiPSC Cardiomyocytes: Front Pharmacol (2021). doi: 10.3389/fphar.2021.604713

Inference of ventricular activation properties from non-invasive electrocardiography

Camps J, Lawson B, Drovandib C, Minchole A, Wanga Z J, Graud V, Burragea K, Rodriguez B. Medical Image Analysis, 2021, 1361-1376.

CalTrack: High-Throughput Automated Calcium Transient Analysis in Cardiomyocytes

Psaras Y, Margara F, Cicconet M, Sparrow A J, Repetti G G, Schmid M, Steeples V, Wilcox J A L, Bueno-Orovio A, Redwood C S, Watkins H C, Robinson P, Rodriguez B, Seidman J G, Seidman C E, Toepfer C N. Circulation Research 2021; 129:326-341.

Human biventricular electromechanical simulations on the progression of electrocardiographic and mechanical abnormalities in post-myocardial infarction

Wang ZJ, Santiago A, Zhou X, Wang L, Margara F, Levrero-Florencio F, Das A, Kelly, C, Dall'Armellina E, Vazquez M, Rodriguez B. EP Europace, Volume 23, (Supplement_1, March 2021, Pages i143–i152.